Insys Therapeutics Inc. (fka INSYQ)

[terry hallinan]

Don't the revered ladies and gentlemen of the FDA care about the ghastly rise in illicit drug overdose deaths?

There are real solutions to the opioid crisis

Public health and drug policy experts say there are solutions to the crisis. First, America could dramatically expand access to addiction treatment — which, based on a 2016 surgeon general report, remains inaccessible to the bulk of people who need it. That would in part entail dramatically boosting access to medications like methadone, buprenorphine, and naltrexone, which are considered the gold standard of treatment for opioid addiction and reduce the mortality rate among opioid addiction patients by half or more.

When France relaxed restrictions on doctors prescribing buprenorphine in response to its own opioid crisis in 1995, the number of people in treatment rose and overdose deaths fell by 79 percent over the following four years.

Beyond treatment, prescribers could also cut back on opioid painkiller prescriptions — to ensure fewer people who misuse the drugs can get them, while still ensuring patients who truly need them get access.....

https://tinyurl.com/ybb3bj7d

The FDA rejected INSY's NDA [new drug application] for a more salubrious form of buprenorphine for saving the lives of overdose victims because it is too dangerous.

Dangerous to who?

The funeral parlors, mortuaries, flower vendors, private prisons and chapels of America should be donating to the esteemed ladies and gentlemen of the FDA.

JMO.

Best, Terry